Transfusion medicine & reactions
Haematology · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Safe transfusion depends on correct identification, appropriate indication and vigilance for reactions. Most serious events are preventable ABO-incompatibility errors; recognition and immediate management save lives.
Red flags
- Escalate acute haemolytic, anaphylactic, TRALI, TACO or septic reactions urgently; involve haematology and critical care as needed
- Report serious reactions via haemovigilance
- Refer chronically transfused patients (haemoglobinopathy) for iron-chelation and specialist management
Assessment
Investigations
- Pre-transfusion: group and screen, crossmatch, two-sample ID rule, bedside positive patient identification
- During reaction: recheck patient and unit identity, FBC, DAT, repeat group/crossmatch, LDH, haptoglobin, bilirubin, coagulation/fibrinogen, blood cultures (patient and unit), U&E, urinalysis for haemoglobinuria
- Chest X-ray for TACO/TRALI
Management
- Any serious reaction: STOP the transfusion, maintain IV access with saline, check identity, assess ABC
- Acute haemolytic/bacterial: resuscitate, inform lab/haematology, return unit, treat shock/DIC, antibiotics if sepsis
- Anaphylaxis: adrenaline, stop, supportive
- TACO: slow/stop, oxygen, diuretic, sit up
- Febrile/mild allergic: slow or pause, paracetamol/antihistamine, restart cautiously
- Use major haemorrhage protocol for massive bleeding
Disposition
Escalate acute haemolytic, anaphylactic, TRALI, TACO or septic reactions urgently; involve haematology and critical care as needed.
Complications & pitfalls
- Fatal ABO-incompatible haemolysis (usually a clerical/identification error), anaphylaxis, TRALI, TACO (leading cause of transfusion death), bacterial sepsis, transfusion-associated circulatory overload, delayed haemolytic reactions, iron overload and alloimmunisation with chronic transfusion
Exam pearls
- The commonest cause of a fatal transfusion reaction is a clerical identification error, not an antibody. Positive patient identification at the bedside, every time, prevents ABO-incompatible haemolysis.
- Monitoring & follow-up: Observe baseline, 15 minutes, and per protocol during each unit; monitor for 24 hours for delayed reactions. Report all events to the laboratory and national haemovigilance (SHOT in UK). Reassess need before each unit (single-unit policy for stable non-bleeding patients). Document and investigate any reaction fully.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.